Search results

End Stage Renal Disease

meeting last week in Boston a novel approach using C5 inhibitor eculizumab in the prevention of acute humoral rejection in highly ...

Treatments

Arm A (IFN with high intensified doses) Aromatase inhibitor Arthroeresis technique Arthrolysis Arthroscopic ... C section C-met inhibitors C4-5 fusion C5 inhibitor Eculizumab C5-6 and C6-7 discectomy and fusion CBT ...